
Journal of Organic Chemistry p. 6719 - 6731 (2020)
Update date:2022-08-04
Topics:
Blasius, Clemens K.
Ren, Bing-Tao
Bürgy, David
Liu, Yan-Kai
Li, Bin
Michalsky, Ina
Wadepohl, Hubert
Deng, Qing-Hai
Gade, Lutz H.
Two synthetic strategies for a new family of neutral NON ligands featuring a bis(oxazolinylmethylidene)isobenzofuran framework (boxman) are reported. A Pd-mediated cyclization reaction forming the isobenzofuran core constitutes the key reaction in the eight-step synthetic route to the nonbackbone-methylated target compound H,Rboxman. In contrast, the introduction of two additional methyl groups provides stereochemical control during backbone construction and thereby access to the methylated derivative Me,Rboxman, which was synthesized in five steps and improved yields. In addition, the synthetic sequence was transferred to the thio analogue, providing access to the NSN ligand H,Rboxmene. Subsequent complexation experiments with iron and cobalt chloride precursors afforded the four-coordinated chlorido complexes Me,RboxmanMCl2 (R = Ph, iPr; M = Fe, Co) and established the boxman family as trans-chelating, bidentate bis(oxazoline) ligands. Application of the latter in the nickel(II)- and zinc(II)-catalyzed α-fluorination of β-ketoesters and oxindoles (up to 98percent yield and 94percent ee) demonstrated their suitability for enantioselective catalysis.
Ji'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
Contact:021-50278900
Address:No.6,Room 201 ,Lane 299,bisheng road ,shanghai ,china
Jintan City Mego Chemical Co., Ltd
Contact:+86-0519-82814387
Address:23# Dengguan Town, Jintan, Jiangsu Province, China
Jinan Kaypharm Chemical Co.,Ltd
Contact:86-0531-86986780
Address:Room101,No189-2,Huayuan Road,Jinan City,Shandong Province
Beijing Cooperate Pharmaceutical Co.,Ltd
website:http://www.cooperate-pharm.com/
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
Doi:10.1002/ejic.200600466
(2006)Doi:10.1039/DT9840002111
(1984)Doi:10.1016/j.bmcl.2012.04.020
(2012)Doi:10.1021/ja00292a032
(1985)Doi:10.1080/10426500600919181
(2007)Doi:10.1021/ja211972x
(2012)